vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and Mosaic Company (The) (MOS). Click either name above to swap in a different company.

Mosaic Company (The) is the larger business by last-quarter revenue ($3.0B vs $77.6M, roughly 38.3× Bioceres Crop Solutions Corp.). Bioceres Crop Solutions Corp. runs the higher net margin — -9.6% vs -17.5%, a 7.9% gap on every dollar of revenue. On growth, Mosaic Company (The) posted the faster year-over-year revenue change (5.6% vs -16.8%). Over the past eight quarters, Mosaic Company (The)'s revenue compounded faster (5.3% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

The Mosaic Company is an American chemical company based in Tampa, Florida, which mines phosphate, potash, and collects urea for fertilizer, through various international distribution networks, and Mosaic Fertilizantes. It is the largest U.S. producer of potash and phosphate fertilizer.

BIOX vs MOS — Head-to-Head

Bigger by revenue
MOS
MOS
38.3× larger
MOS
$3.0B
$77.6M
BIOX
Growing faster (revenue YoY)
MOS
MOS
+22.4% gap
MOS
5.6%
-16.8%
BIOX
Higher net margin
BIOX
BIOX
7.9% more per $
BIOX
-9.6%
-17.5%
MOS
Faster 2-yr revenue CAGR
MOS
MOS
Annualised
MOS
5.3%
-8.4%
BIOX

Income Statement — Q1 2026 vs Q4 2025

Metric
BIOX
BIOX
MOS
MOS
Revenue
$77.6M
$3.0B
Net Profit
$-7.4M
$-519.5M
Gross Margin
46.8%
11.5%
Operating Margin
9.3%
-3.4%
Net Margin
-9.6%
-17.5%
Revenue YoY
-16.8%
5.6%
Net Profit YoY
-20.2%
-407.4%
EPS (diluted)
$-0.12
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
MOS
MOS
Q4 25
$3.0B
Q3 25
$77.6M
$3.5B
Q2 25
$3.0B
Q1 25
$60.6M
$2.6B
Q4 24
$98.8M
$2.8B
Q3 24
$93.3M
$2.8B
Q2 24
$2.8B
Q1 24
$84.0M
$2.7B
Net Profit
BIOX
BIOX
MOS
MOS
Q4 25
$-519.5M
Q3 25
$-7.4M
$411.4M
Q2 25
$410.7M
Q1 25
$-1.6M
$238.1M
Q4 24
$605.2K
$169.0M
Q3 24
$-6.2M
$122.2M
Q2 24
$-161.5M
Q1 24
$9.8M
$45.2M
Gross Margin
BIOX
BIOX
MOS
MOS
Q4 25
11.5%
Q3 25
46.8%
16.0%
Q2 25
17.3%
Q1 25
39.4%
18.6%
Q4 24
42.0%
10.7%
Q3 24
40.2%
14.8%
Q2 24
14.0%
Q1 24
50.8%
14.9%
Operating Margin
BIOX
BIOX
MOS
MOS
Q4 25
-3.4%
Q3 25
9.3%
9.8%
Q2 25
8.1%
Q1 25
1.5%
12.9%
Q4 24
14.5%
3.5%
Q3 24
2.5%
4.1%
Q2 24
8.3%
Q1 24
15.7%
6.5%
Net Margin
BIOX
BIOX
MOS
MOS
Q4 25
-17.5%
Q3 25
-9.6%
11.9%
Q2 25
13.7%
Q1 25
-2.6%
9.1%
Q4 24
0.6%
6.0%
Q3 24
-6.6%
4.3%
Q2 24
-5.7%
Q1 24
11.6%
1.7%
EPS (diluted)
BIOX
BIOX
MOS
MOS
Q4 25
$-1.63
Q3 25
$-0.12
$1.29
Q2 25
$1.29
Q1 25
$-0.02
$0.75
Q4 24
$0.00
$0.53
Q3 24
$-0.10
$0.38
Q2 24
$-0.50
Q1 24
$0.14
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
MOS
MOS
Cash + ST InvestmentsLiquidity on hand
$15.5M
$276.6M
Total DebtLower is stronger
$4.3B
Stockholders' EquityBook value
$288.3M
$12.1B
Total Assets
$734.9M
$24.5B
Debt / EquityLower = less leverage
0.35×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
MOS
MOS
Q4 25
$276.6M
Q3 25
$15.5M
$153.3M
Q2 25
$286.2M
Q1 25
$38.5M
$259.2M
Q4 24
$29.2M
$272.8M
Q3 24
$32.3M
$301.6M
Q2 24
$322.0M
Q1 24
$16.4M
$336.7M
Total Debt
BIOX
BIOX
MOS
MOS
Q4 25
$4.3B
Q3 25
$3.4B
Q2 25
$3.3B
Q1 25
$3.3B
Q4 24
$3.3B
Q3 24
$3.2B
Q2 24
$3.2B
Q1 24
$3.2B
Stockholders' Equity
BIOX
BIOX
MOS
MOS
Q4 25
$12.1B
Q3 25
$288.3M
$12.8B
Q2 25
$12.4B
Q1 25
$345.0M
$11.8B
Q4 24
$346.3M
$11.5B
Q3 24
$346.0M
$11.8B
Q2 24
$11.7B
Q1 24
$348.5M
$12.0B
Total Assets
BIOX
BIOX
MOS
MOS
Q4 25
$24.5B
Q3 25
$734.9M
$24.7B
Q2 25
$24.3B
Q1 25
$798.2M
$23.2B
Q4 24
$835.2M
$22.9B
Q3 24
$827.3M
$23.3B
Q2 24
$22.6B
Q1 24
$836.1M
$22.9B
Debt / Equity
BIOX
BIOX
MOS
MOS
Q4 25
0.35×
Q3 25
0.26×
Q2 25
0.27×
Q1 25
0.28×
Q4 24
0.29×
Q3 24
0.27×
Q2 24
0.27×
Q1 24
0.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
MOS
MOS
Operating Cash FlowLast quarter
$14.4M
$-56.1M
Free Cash FlowOCF − Capex
$-405.7M
FCF MarginFCF / Revenue
-13.6%
Capex IntensityCapex / Revenue
11.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-534.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
MOS
MOS
Q4 25
$-56.1M
Q3 25
$14.4M
$228.5M
Q2 25
$609.5M
Q1 25
$23.3M
$42.9M
Q4 24
$-5.4M
$219.3M
Q3 24
$5.2M
$312.9M
Q2 24
$847.0M
Q1 24
$-17.4M
$-80.0M
Free Cash Flow
BIOX
BIOX
MOS
MOS
Q4 25
$-405.7M
Q3 25
$-135.9M
Q2 25
$304.9M
Q1 25
$-297.9M
Q4 24
$-74.8M
Q3 24
$72.1M
Q2 24
$513.1M
Q1 24
$-463.0M
FCF Margin
BIOX
BIOX
MOS
MOS
Q4 25
-13.6%
Q3 25
-3.9%
Q2 25
10.1%
Q1 25
-11.4%
Q4 24
-2.7%
Q3 24
2.6%
Q2 24
18.2%
Q1 24
-17.3%
Capex Intensity
BIOX
BIOX
MOS
MOS
Q4 25
11.8%
Q3 25
10.6%
Q2 25
10.1%
Q1 25
13.0%
Q4 24
10.4%
Q3 24
8.6%
Q2 24
11.9%
Q1 24
14.3%
Cash Conversion
BIOX
BIOX
MOS
MOS
Q4 25
Q3 25
0.56×
Q2 25
1.48×
Q1 25
0.18×
Q4 24
-8.85×
1.30×
Q3 24
2.56×
Q2 24
Q1 24
-1.78×
-1.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons